D. Lovell

1.0k total citations
30 papers, 488 citations indexed

About

D. Lovell is a scholar working on Hematology, Speech and Hearing and Immunology. According to data from OpenAlex, D. Lovell has authored 30 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 14 papers in Speech and Hearing and 10 papers in Immunology. Recurrent topics in D. Lovell's work include Autoimmune and Inflammatory Disorders Research (21 papers), Adolescent and Pediatric Healthcare (14 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). D. Lovell is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (21 papers), Adolescent and Pediatric Healthcare (14 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). D. Lovell collaborates with scholars based in United States, Italy and Switzerland. D. Lovell's co-authors include Stephen N. Harris, Elizabeth J. King, Alberto Martini, Edward H. Giannini, Earl D. Silverman, Nicolino Ruperto, Murray H. Passo, Robert P. Sundel, R M Laxer and Lawrence Zemel and has published in prestigious journals such as Nature, Cellular and Molecular Life Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

D. Lovell

27 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Lovell United States 8 231 151 100 81 69 30 488
R.H. Sutton Australia 16 27 0.1× 51 0.3× 28 0.3× 16 0.2× 111 1.6× 56 743
Katie Frith Australia 13 21 0.1× 64 0.4× 17 0.2× 32 0.4× 67 1.0× 28 907
Shelley L. Schmidt United States 14 62 0.3× 33 0.2× 7 0.1× 37 0.5× 83 1.2× 20 1.0k
Karen Rickards United Kingdom 13 39 0.2× 65 0.4× 28 0.3× 3 0.0× 43 0.6× 32 425
Pascal Dumont France 18 12 0.1× 41 0.3× 11 0.1× 114 1.4× 35 0.5× 41 903
J. Capdeville France 10 22 0.1× 83 0.5× 19 0.2× 114 1.4× 11 0.2× 28 646
Joan Garriga Spain 10 33 0.1× 127 0.8× 35 0.3× 7 0.1× 19 0.3× 24 561
Llorenç Badiella Spain 14 34 0.1× 37 0.2× 6 0.1× 8 0.1× 58 0.8× 34 734
Donna King United States 19 10 0.0× 52 0.3× 5 0.1× 77 1.0× 320 4.6× 35 1.1k
José Eduardo Martins Brazil 14 23 0.1× 8 0.1× 4 0.0× 94 1.2× 41 0.6× 35 460

Countries citing papers authored by D. Lovell

Since Specialization
Citations

This map shows the geographic impact of D. Lovell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lovell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lovell more than expected).

Fields of papers citing papers by D. Lovell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lovell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lovell. The network helps show where D. Lovell may publish in the future.

Co-authorship network of co-authors of D. Lovell

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lovell. A scholar is included among the top collaborators of D. Lovell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lovell. D. Lovell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ruperto, Nicolino, Isabelle Koné‐Paut, Bo Magnusson, et al.. (2014). Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data. Pediatric Rheumatology. 12(S1). 4 indexed citations
3.
Ravelli, Angelo, Nicolino Ruperto, Pierre Quartier, et al.. (2014). Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset. Pediatric Rheumatology. 12(S1).
4.
Wulffraat, NM, Nicolino Ruperto, Yosef Uziel, et al.. (2014). Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients. Pediatric Rheumatology. 12(S1). 1 indexed citations
5.
Quartier, Pierre, Nicolino Ruperto, Kenneth N. Schikler, et al.. (2014). Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis. Pediatric Rheumatology. 12(S1). 1 indexed citations
6.
Ravelli, Angelo, Nicolino Ruperto, Pierre Quartier, et al.. (2014). Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data. Pediatric Rheumatology. 12(S1).
7.
Malattia, Clara, Nicolino Ruperto, Elena Palmisani, et al.. (2013). Assessment of Radiographic Progression in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2-Year Results From the TENDER Trial. UCL Discovery (University College London). 65. 1 indexed citations
8.
Ruperto, Nicolino, D. Lovell, Kateřina Jarošová, et al.. (2013). PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis. Pediatric Rheumatology. 11(S2). 1 indexed citations
9.
Benedetti, Fabrizio De, Nicolino Ruperto, Alexei A. Grom, et al.. (2013). PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study. Pediatric Rheumatology. 11(S2). 1 indexed citations
10.
11.
Ruperto, Nicolino, D. Lovell, Gavin C. Higgins, et al.. (2011). Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis. Pediatric Rheumatology. 9(S1). 5 indexed citations
12.
Huang, Bin, MH Weisman, Jonathan Samuels, et al.. (2011). Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial. Pediatric Rheumatology. 9(S1). 3 indexed citations
13.
Martini, Alberto & D. Lovell. (2010). Juvenile idiopathic arthritis: state of the art and future perspectives. Annals of the Rheumatic Diseases. 69(7). 1260–1263. 88 indexed citations
14.
15.
Ruperto, Nicolino, D. Lovell, Pierre Quartier, et al.. (2008). Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients. Pediatric Rheumatology. 6(S1). 1 indexed citations
16.
Ruperto, Nicolino, D. Lovell, Eliana Paz, et al.. (2006). Efficacy and safety of Abatacept in children and adolescents with active Juvenile Idiopathic Arthritis (JIA). 2. 248. 3 indexed citations
17.
Giannini, Edward H., et al.. (1996). Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.. PubMed. 23(5). 919–24. 40 indexed citations
18.
Lovell, D.. (1992). Newer functional outcome measurements in juvenile rheumatoid arthritis: a progress report.. PubMed. 33. 28–31. 10 indexed citations
19.
Slater, T. F. & D. Lovell. (1961). Increased serum diphenylamine reaction in patients with leukemia. Cellular and Molecular Life Sciences. 17(6). 272–274. 5 indexed citations
20.
Lovell, D. & T. A. J. Prankerd. (1961). Effect of Quinones on the Uptake of Oxygen by Red Cells. Nature. 192(4802). 561–562. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.H. Sutton Breakdown of academic impact, for papers by Katie Frith Breakdown of academic impact, for papers by Shelley L. Schmidt Breakdown of academic impact, for papers by Karen Rickards Breakdown of academic impact, for papers by Pascal Dumont Breakdown of academic impact, for papers by J. Capdeville Breakdown of academic impact, for papers by Joan Garriga Breakdown of academic impact, for papers by Llorenç Badiella Breakdown of academic impact, for papers by Donna King Breakdown of academic impact, for papers by José Eduardo Martins
Rankless by CCL
2026